List of Janssen Pharmaceuticals patents

Patents where

Current Assignee

Name

Janssen Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10538786 Recombinant arterivirus replicon systems and uses thereof	Patent 10538786 was granted and assigned to Janssen Pharmaceuticals on January, 2020 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	10538786	January 21, 2020
‌ US Patent 11266627 Compositions and methods for the treatment of depression	Patent 11266627 was granted and assigned to Janssen Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11266627	March 8, 2022
‌ US Patent 11491220 Methods of producing bioconjugates of	Patent 11491220 was granted and assigned to Janssen Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	11491220	November 8, 2022
‌ US Patent 11446446 Accessory for an injection device including a grip for a needle cap	Patent 11446446 was granted and assigned to Janssen Pharmaceuticals on September, 2022 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11446446	September 20, 2022
‌ US Patent 11555205 Recombinant arterivirus replicon systems and uses thereof	Patent 11555205 was granted and assigned to Janssen Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11555205	January 17, 2023
‌ US Patent 11602599 Accessory for an injection device including a pivotable cover	Patent 11602599 was granted and assigned to Janssen Pharmaceuticals on March, 2023 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11602599	March 14, 2023
‌ US Patent 11607216 Adaptive responses from smart packaging of drug delivery absorbable adjuncts	Patent 11607216 was granted and assigned to Janssen Pharmaceuticals on March, 2023 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11607216	March 21, 2023
‌ US Patent 7618945 Heteroaryl peptidomimetics as thrombin receptor antagonists	Patent 7618945 was granted and assigned to Janssen Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	7618945	November 17, 2009
‌ US Patent 11364310 Recombinant virus replicon systems and uses thereof	Patent 11364310 was granted and assigned to Janssen Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11364310	June 21, 2022
‌ US Patent 11033633 ExPEC glycoconjugate vaccine formulations	Patent 11033633 was granted and assigned to Janssen Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11033633	June 15, 2021
‌ US Patent 10525145 ExPEC glycoconjugate vaccine formulations	Patent 10525145 was granted and assigned to Janssen Pharmaceuticals on January, 2020 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	10525145	January 7, 2020
‌ US Patent 10159751 ExPEC glycoconjugate vaccine formulations	Patent 10159751 was granted and assigned to Janssen Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	10159751	December 25, 2018
‌ US Patent 8741887 Azetidinyl diamides as monoacylglycerol lipase inhibitors	Patent 8741887 was granted and assigned to Janssen Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	8741887	June 3, 2014
‌ US Patent 8685990 Pyrimidine compounds as delta opioid receptor modulators	Patent 8685990 was granted and assigned to Janssen Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	8685990	April 1, 2014
‌ US Patent 8399454 Azetidinyl diamides as monoacylglycerol lipase inhibitors	Patent 8399454 was granted and assigned to Janssen Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	8399454	March 19, 2013
‌ US Patent D946141 Autoinjector	Patent D946141 was granted and assigned to Janssen Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	D946141	March 15, 2022
‌ US Patent D956215 Autoinjector	Patent D956215 was granted and assigned to Janssen Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	D956215	June 28, 2022
‌ US Patent 7618983 Bicyclic triazole α4 integrin inhibitors	Patent 7618983 was granted and assigned to Janssen Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	7618983	November 17, 2009
‌ US Patent RE49517 Pyrazoles	Patent RE49517 was granted and assigned to Janssen Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	RE49517	May 2, 2023
‌ US Patent 8143259 Cold menthol receptor antagonists	Patent 8143259 was granted and assigned to Janssen Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	8143259	March 27, 2012
‌ US Patent 10155727 Pyrazoles	Patent 10155727 was granted and assigned to Janssen Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	10155727	December 18, 2018
‌ US Patent 11421003 FimH mutant, compositions therewith and use thereof	Patent 11421003 was granted and assigned to Janssen Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	11421003	August 23, 2022
‌ US Patent 8426401 Azetidinyl diamides as monoacylglycerol lipase inhibitors	Patent 8426401 was granted and assigned to Janssen Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.		Janssen Pharmaceuticals	United States Patent and Trademark Office	8426401	April 23, 2013
‌ US Patent 10323021 Triazoles as NR2B receptor inhibitors	Patent 10323021 was granted and assigned to Janssen Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	10323021	June 18, 2019
‌ US Patent D946750 Grip accessory for an injection device	Patent D946750 was granted and assigned to Janssen Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.	Janssen Pharmaceuticals	Janssen Pharmaceuticals	United States Patent and Trademark Office	D946750	March 22, 2022

...

Results per page:

142 results

0 selected

142 results

0 selected